| 2026-08-06 | Forminard ElizabethEVP, Chief Legal Officer | Sale | 6,574 | -$1.7M |
| 2026-08-06 | Forminard ElizabethEVP, Chief Legal Officer | Sale | 9,344 | -$2.4M |
| 2026-08-06 | Forminard ElizabethEVP, Chief Legal Officer | Exercise | 9,344 | $1.2M |
| 2026-08-05 | Duato JoaquinCEO and Chairman of the Board | Sale | 6,523 | -$1.7M |
| 2026-08-05 | Duato JoaquinCEO and Chairman of the Board | Sale | 41,957 | -$10.8M |
| 2026-07-20 | Broadhurst VanessaEVP, Global Corp Affairs | Sale | 23,054 | -$5.8M |
| 2026-07-20 | Broadhurst VanessaEVP, Global Corp Affairs | Exercise | 11,925 | $1.6M |
| 2026-07-20 | Broadhurst VanessaEVP, Global Corp Affairs | Exercise | 11,129 | $1.4M |
| 2026-06-11 | Wengel Kathryn EEVP, Chief TO and Risk Officer | Sale | 10,000 | -$2.4M |
| 2026-06-11 | Wengel Kathryn EEVP, Chief TO and Risk Officer | Exercise | 10,000 | $1.2M |
| 2026-05-01 | REED JOHN CEVP, Innovative Medicine, R&D | Exercise | 25,255 | — |
| 2026-05-01 | REED JOHN CEVP, Innovative Medicine, R&D | Tax withhold | 11,002 | -$2.5M |
| 2026-02-27 | Decker Robert JVP Corporate Controller | Exercise | 4,075 | $471.4K |
| 2026-02-27 | Decker Robert JVP Corporate Controller | Sale | 4,075 | -$1.0M |
| 2026-02-20 | Schmid TimothyEVP, WW Chair, MedTech | Sale | 1,322 | -$324.8K |
| 2026-02-18 | Schmid TimothyEVP, WW Chair, MedTech | Exercise | 13,625 | $1.6M |
| 2026-02-18 | Schmid TimothyEVP, WW Chair, MedTech | Sale | 13,625 | -$3.3M |
| 2026-02-18 | Schmid TimothyEVP, WW Chair, MedTech | Exercise | 8,998 | $1.2M |
| 2026-02-18 | Schmid TimothyEVP, WW Chair, MedTech | Sale | 8,998 | -$2.2M |
| 2026-02-17 | Swanson James D.EVP, CIO | Exercise | 20,521 | $3.4M |
| 2026-02-17 | Swanson James D.EVP, CIO | Sale | 20,521 | -$5.0M |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Exercise | 21,721 | $3.4M |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 21,721 | -$5.3M |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Exercise | 29,927 | $4.7M |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 29,927 | -$7.3M |
| 2026-02-17 | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 2,283 | -$554.8K |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Exercise | 19,241 | $2.2M |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Sale | 19,241 | -$4.7M |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Exercise | 12,066 | $1.6M |
| 2026-02-17 | Wolk Joseph JExec VP, CFO | Sale | 12,066 | -$2.9M |